| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Kinase C | 82 | 2017 | 1202 | 7.920 |
Why?
|
| Diabetic Angiopathies | 36 | 2024 | 803 | 5.390 |
Why?
|
| Diabetic Nephropathies | 28 | 2022 | 973 | 4.960 |
Why?
|
| Diabetes Mellitus, Experimental | 41 | 2022 | 1119 | 4.220 |
Why?
|
| Insulin Resistance | 40 | 2023 | 3963 | 3.880 |
Why?
|
| Diabetic Retinopathy | 32 | 2024 | 1274 | 3.390 |
Why?
|
| Diabetes Mellitus, Type 1 | 34 | 2021 | 3415 | 3.290 |
Why?
|
| Insulin | 64 | 2023 | 6596 | 2.800 |
Why?
|
| Endothelium, Vascular | 51 | 2021 | 4431 | 2.550 |
Why?
|
| Retinal Vessels | 30 | 2021 | 852 | 2.430 |
Why?
|
| Protein Kinase C-delta | 10 | 2017 | 114 | 2.170 |
Why?
|
| Diglycerides | 27 | 2010 | 177 | 2.000 |
Why?
|
| Insulin Receptor Substrate Proteins | 13 | 2021 | 557 | 1.990 |
Why?
|
| Muscle, Smooth, Vascular | 28 | 2021 | 1493 | 1.970 |
Why?
|
| Diabetes Mellitus | 26 | 2024 | 5840 | 1.940 |
Why?
|
| Glucose | 32 | 2019 | 4346 | 1.830 |
Why?
|
| Hyperglycemia | 32 | 2023 | 1376 | 1.820 |
Why?
|
| Receptor, Insulin | 33 | 2019 | 835 | 1.800 |
Why?
|
| Pyruvate Kinase | 3 | 2022 | 189 | 1.770 |
Why?
|
| Retina | 31 | 2024 | 2659 | 1.680 |
Why?
|
| Isoenzymes | 33 | 2017 | 1687 | 1.670 |
Why?
|
| Kidney Glomerulus | 14 | 2019 | 568 | 1.620 |
Why?
|
| Vascular Endothelial Growth Factor A | 35 | 2022 | 3492 | 1.530 |
Why?
|
| Podocytes | 4 | 2022 | 405 | 1.350 |
Why?
|
| Endothelial Growth Factors | 19 | 2003 | 673 | 1.340 |
Why?
|
| Atherosclerosis | 12 | 2022 | 3408 | 1.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 25 | 2024 | 12148 | 1.340 |
Why?
|
| Endothelial Cells | 17 | 2023 | 3548 | 1.300 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 3 | 2016 | 120 | 1.280 |
Why?
|
| Lymphokines | 18 | 2003 | 927 | 1.280 |
Why?
|
| Enzyme Activation | 36 | 2017 | 3597 | 1.250 |
Why?
|
| Rats, Zucker | 15 | 2017 | 131 | 1.230 |
Why?
|
| Periodontitis | 3 | 2023 | 568 | 1.210 |
Why?
|
| Vitreous Body | 5 | 2024 | 399 | 1.180 |
Why?
|
| Diabetes Complications | 13 | 2015 | 1315 | 1.130 |
Why?
|
| Retinol-Binding Proteins | 3 | 2024 | 67 | 1.100 |
Why?
|
| Vitamin E | 12 | 2005 | 872 | 1.080 |
Why?
|
| Endothelin-1 | 8 | 2013 | 302 | 1.030 |
Why?
|
| Maleimides | 17 | 2011 | 113 | 1.030 |
Why?
|
| Diabetic Cardiomyopathies | 2 | 2017 | 90 | 1.000 |
Why?
|
| Cattle | 47 | 2013 | 3849 | 0.990 |
Why?
|
| Hyperplasia | 3 | 2019 | 1152 | 0.970 |
Why?
|
| Receptor, IGF Type 1 | 4 | 2019 | 379 | 0.960 |
Why?
|
| Oxidative Stress | 14 | 2014 | 3113 | 0.950 |
Why?
|
| Rats | 74 | 2017 | 23742 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2023 | 2455 | 0.920 |
Why?
|
| Myocardium | 13 | 2017 | 4726 | 0.920 |
Why?
|
| Aqueous Humor | 1 | 2024 | 153 | 0.890 |
Why?
|
| Diabetic Neuropathies | 5 | 2013 | 405 | 0.890 |
Why?
|
| Animals | 176 | 2023 | 168459 | 0.890 |
Why?
|
| Eye Proteins | 4 | 2022 | 633 | 0.850 |
Why?
|
| Angiotensin II | 5 | 2013 | 849 | 0.830 |
Why?
|
| Phosphatidylinositol 3-Kinases | 15 | 2023 | 2865 | 0.820 |
Why?
|
| Signal Transduction | 39 | 2021 | 23445 | 0.810 |
Why?
|
| Nitric Oxide Synthase Type III | 10 | 2017 | 705 | 0.770 |
Why?
|
| Enzyme Inhibitors | 27 | 2012 | 3712 | 0.750 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2024 | 3810 | 0.740 |
Why?
|
| Cells, Cultured | 66 | 2016 | 18965 | 0.730 |
Why?
|
| Retinal Neurons | 1 | 2021 | 67 | 0.730 |
Why?
|
| Apolipoproteins E | 5 | 2022 | 1444 | 0.720 |
Why?
|
| Endothelium | 14 | 2022 | 765 | 0.690 |
Why?
|
| Insulin-Secreting Cells | 4 | 2019 | 901 | 0.640 |
Why?
|
| Rats, Sprague-Dawley | 35 | 2017 | 8181 | 0.630 |
Why?
|
| Somatomedins | 12 | 1990 | 179 | 0.620 |
Why?
|
| Capillaries | 17 | 2021 | 755 | 0.610 |
Why?
|
| Indoles | 17 | 2011 | 1833 | 0.590 |
Why?
|
| Enzymes | 1 | 2019 | 257 | 0.580 |
Why?
|
| Hyperlipidemias | 2 | 2017 | 771 | 0.580 |
Why?
|
| Kidney | 9 | 2019 | 7048 | 0.570 |
Why?
|
| Mice | 54 | 2023 | 81525 | 0.560 |
Why?
|
| Cytokines | 6 | 2022 | 7396 | 0.560 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2005 | 1651 | 0.560 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2021 | 699 | 0.550 |
Why?
|
| Hyperinsulinism | 4 | 2016 | 400 | 0.550 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 2013 | 817 | 0.540 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2017 | 111 | 0.530 |
Why?
|
| Pericytes | 4 | 2009 | 293 | 0.530 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 764 | 0.530 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2007 | 353 | 0.520 |
Why?
|
| Blood Proteins | 3 | 2007 | 1173 | 0.520 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 215 | 0.520 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 295 | 0.520 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2009 | 1171 | 0.520 |
Why?
|
| Growth Substances | 8 | 2002 | 768 | 0.510 |
Why?
|
| Immediate-Early Proteins | 3 | 2005 | 449 | 0.510 |
Why?
|
| Insulin-Like Growth Factor I | 10 | 2019 | 1934 | 0.510 |
Why?
|
| Aorta | 21 | 2013 | 2042 | 0.500 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 1886 | 0.480 |
Why?
|
| Hypoglycemic Agents | 5 | 2017 | 3085 | 0.480 |
Why?
|
| Receptors, Growth Factor | 6 | 2002 | 326 | 0.470 |
Why?
|
| Receptors, Glucagon | 2 | 2012 | 90 | 0.470 |
Why?
|
| Vascular Endothelial Growth Factors | 18 | 2003 | 748 | 0.470 |
Why?
|
| Tunica Intima | 1 | 2016 | 459 | 0.470 |
Why?
|
| HLA-DQ Antigens | 2 | 2011 | 191 | 0.460 |
Why?
|
| Macrophages | 4 | 2017 | 5769 | 0.460 |
Why?
|
| Capillary Permeability | 7 | 2007 | 773 | 0.460 |
Why?
|
| Protein Kinase C-alpha | 4 | 2014 | 113 | 0.460 |
Why?
|
| Phosphorylation | 24 | 2017 | 8320 | 0.460 |
Why?
|
| Macrophage Activation | 1 | 2017 | 553 | 0.450 |
Why?
|
| Vasculitis | 2 | 2014 | 521 | 0.450 |
Why?
|
| RNA, Messenger | 29 | 2012 | 12795 | 0.440 |
Why?
|
| Carbohydrate Metabolism | 1 | 2014 | 263 | 0.440 |
Why?
|
| Protein Kinase C-epsilon | 3 | 2014 | 43 | 0.430 |
Why?
|
| Mice, Transgenic | 14 | 2019 | 9539 | 0.430 |
Why?
|
| Gingivitis | 1 | 2014 | 124 | 0.430 |
Why?
|
| Endothelins | 7 | 1996 | 127 | 0.430 |
Why?
|
| HLA-DR Antigens | 2 | 2011 | 602 | 0.420 |
Why?
|
| Cardiovascular Diseases | 15 | 2018 | 15500 | 0.420 |
Why?
|
| Blood Glucose | 16 | 2017 | 6391 | 0.420 |
Why?
|
| Platelet-Derived Growth Factor | 5 | 2012 | 618 | 0.410 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 1809 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 10 | 2008 | 2645 | 0.400 |
Why?
|
| Pigment Epithelium of Eye | 3 | 2007 | 209 | 0.400 |
Why?
|
| Antioxidants | 9 | 2013 | 1668 | 0.390 |
Why?
|
| Apoptosis | 6 | 2017 | 9486 | 0.390 |
Why?
|
| Diabetic Foot | 1 | 2016 | 380 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 14 | 2022 | 22169 | 0.390 |
Why?
|
| Gene Expression Regulation | 16 | 2015 | 11903 | 0.390 |
Why?
|
| NF-kappa B | 8 | 2017 | 2490 | 0.380 |
Why?
|
| Humans | 138 | 2024 | 761504 | 0.380 |
Why?
|
| Male | 95 | 2024 | 360804 | 0.380 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 77 | 0.380 |
Why?
|
| Mice, Knockout | 17 | 2017 | 14414 | 0.380 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 488 | 0.370 |
Why?
|
| Obesity | 11 | 2022 | 12947 | 0.370 |
Why?
|
| Awards and Prizes | 2 | 2016 | 360 | 0.360 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 891 | 0.350 |
Why?
|
| C-Peptide | 3 | 2019 | 440 | 0.350 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2012 | 364 | 0.340 |
Why?
|
| Diacylglycerol Kinase | 5 | 1999 | 46 | 0.320 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2015 | 691 | 0.320 |
Why?
|
| Mesangial Cells | 1 | 2008 | 23 | 0.310 |
Why?
|
| Blood Vessels | 4 | 2008 | 1113 | 0.310 |
Why?
|
| Wound Healing | 2 | 2016 | 2805 | 0.300 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2002 | 1626 | 0.300 |
Why?
|
| Deoxyglucose | 4 | 2019 | 333 | 0.300 |
Why?
|
| Glypicans | 1 | 2007 | 33 | 0.300 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 265 | 0.290 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.290 |
Why?
|
| Mitochondria | 2 | 2019 | 3624 | 0.290 |
Why?
|
| Dyslipidemias | 2 | 2012 | 868 | 0.290 |
Why?
|
| Receptors, Cell Surface | 11 | 1991 | 2822 | 0.280 |
Why?
|
| Heme Oxygenase-1 | 2 | 2012 | 366 | 0.280 |
Why?
|
| Cognition | 3 | 2021 | 6990 | 0.280 |
Why?
|
| Angiotensins | 2 | 2007 | 143 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2019 | 546 | 0.280 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 1999 | 277 | 0.270 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 1999 | 167 | 0.270 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 263 | 0.270 |
Why?
|
| Lipids | 1 | 2017 | 3341 | 0.270 |
Why?
|
| Glycolysis | 4 | 2019 | 835 | 0.270 |
Why?
|
| Fibroblasts | 5 | 2016 | 4141 | 0.260 |
Why?
|
| Inflammation | 6 | 2022 | 10773 | 0.260 |
Why?
|
| Glomerular Filtration Rate | 5 | 2019 | 2176 | 0.250 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.250 |
Why?
|
| Peptides | 12 | 2012 | 4358 | 0.240 |
Why?
|
| Membrane Proteins | 4 | 2007 | 7856 | 0.240 |
Why?
|
| Up-Regulation | 1 | 2013 | 4124 | 0.230 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 4 | 1997 | 477 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4575 | 0.220 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 1055 | 0.220 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 18252 | 0.220 |
Why?
|
| Chemokine CXCL1 | 1 | 2023 | 101 | 0.210 |
Why?
|
| Cell Movement | 5 | 2019 | 5203 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2006 | 484 | 0.210 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 461 | 0.210 |
Why?
|
| Insulin-Like Growth Factor II | 7 | 1991 | 269 | 0.210 |
Why?
|
| Drug Implants | 2 | 2017 | 230 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2012 | 687 | 0.210 |
Why?
|
| Rats, Inbred Lew | 2 | 2019 | 1157 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2017 | 2469 | 0.210 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 26125 | 0.210 |
Why?
|
| Kidney Cortex | 4 | 2009 | 169 | 0.210 |
Why?
|
| Communication Barriers | 1 | 2006 | 413 | 0.200 |
Why?
|
| Aged | 25 | 2024 | 169289 | 0.200 |
Why?
|
| Cardiomegaly | 2 | 2009 | 590 | 0.200 |
Why?
|
| Middle Aged | 31 | 2024 | 220895 | 0.200 |
Why?
|
| Microcirculation | 10 | 2003 | 1273 | 0.200 |
Why?
|
| Blood Circulation | 3 | 2005 | 248 | 0.200 |
Why?
|
| Blotting, Western | 6 | 2017 | 5035 | 0.200 |
Why?
|
| Time Factors | 16 | 2019 | 39967 | 0.200 |
Why?
|
| Edema | 1 | 2006 | 766 | 0.200 |
Why?
|
| 3-O-Methylglucose | 2 | 2019 | 37 | 0.200 |
Why?
|
| Receptors, Endothelin | 4 | 1996 | 56 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.200 |
Why?
|
| Aldehyde Reductase | 4 | 2005 | 71 | 0.190 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 56 | 0.190 |
Why?
|
| Female | 42 | 2024 | 392644 | 0.190 |
Why?
|
| Cardiomyopathies | 4 | 2002 | 1964 | 0.190 |
Why?
|
| Retinal Neovascularization | 2 | 2002 | 288 | 0.180 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 1349 | 0.180 |
Why?
|
| Glomerular Mesangium | 4 | 2000 | 98 | 0.180 |
Why?
|
| Immunoblotting | 3 | 2016 | 1646 | 0.180 |
Why?
|
| Neutrophil Infiltration | 1 | 2023 | 390 | 0.180 |
Why?
|
| Recombinant Proteins | 6 | 2019 | 6534 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.180 |
Why?
|
| Kinetics | 15 | 1999 | 6374 | 0.180 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2008 | 740 | 0.180 |
Why?
|
| Fibrosis | 4 | 2017 | 2049 | 0.180 |
Why?
|
| Enzyme Activators | 1 | 2000 | 57 | 0.180 |
Why?
|
| Vascular Diseases | 2 | 2000 | 1161 | 0.170 |
Why?
|
| Adipose Tissue | 7 | 2006 | 3312 | 0.170 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 3826 | 0.170 |
Why?
|
| Case-Control Studies | 8 | 2021 | 22176 | 0.170 |
Why?
|
| Regional Blood Flow | 8 | 2000 | 1496 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 4 | 2003 | 908 | 0.170 |
Why?
|
| Streptozocin | 3 | 2017 | 194 | 0.170 |
Why?
|
| Gene Expression | 8 | 2021 | 7581 | 0.170 |
Why?
|
| Glycerides | 2 | 1989 | 67 | 0.170 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 64 | 0.170 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 2917 | 0.170 |
Why?
|
| Cell Division | 10 | 2002 | 4465 | 0.160 |
Why?
|
| Glutathione | 2 | 2012 | 583 | 0.160 |
Why?
|
| Dental Plaque Index | 1 | 2019 | 95 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2016 | 5671 | 0.160 |
Why?
|
| Glycosylation | 4 | 2008 | 1098 | 0.160 |
Why?
|
| Periodontal Attachment Loss | 1 | 2019 | 147 | 0.160 |
Why?
|
| HLA-A Antigens | 1 | 2019 | 223 | 0.160 |
Why?
|
| Acids | 1 | 2019 | 125 | 0.160 |
Why?
|
| Cell Line | 7 | 2017 | 15601 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 2206 | 0.160 |
Why?
|
| Metabolomics | 2 | 2019 | 1659 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 2022 | 2135 | 0.160 |
Why?
|
| Connective Tissue Growth Factor | 3 | 2005 | 92 | 0.160 |
Why?
|
| Phosphoserine | 2 | 1999 | 203 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1246 | 0.160 |
Why?
|
| Fluorescein Angiography | 7 | 2000 | 1059 | 0.160 |
Why?
|
| Protein Isoforms | 2 | 2002 | 1699 | 0.150 |
Why?
|
| Transfection | 7 | 2017 | 5774 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 2141 | 0.150 |
Why?
|
| Protective Agents | 1 | 2019 | 150 | 0.150 |
Why?
|
| Serpins | 1 | 2000 | 247 | 0.150 |
Why?
|
| Phlorhizin | 1 | 2017 | 37 | 0.150 |
Why?
|
| Retinoblastoma Protein | 1 | 2002 | 672 | 0.150 |
Why?
|
| Vasodilation | 3 | 2010 | 962 | 0.150 |
Why?
|
| Periodontal Diseases | 2 | 2014 | 451 | 0.150 |
Why?
|
| RNA Interference | 3 | 2017 | 2831 | 0.150 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2019 | 203 | 0.150 |
Why?
|
| Models, Biological | 8 | 2015 | 9469 | 0.150 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2017 | 12 | 0.150 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 385 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2022 | 727 | 0.140 |
Why?
|
| Half-Life | 2 | 2016 | 651 | 0.140 |
Why?
|
| Tyrosine | 4 | 2013 | 1440 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2319 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2010 | 2781 | 0.140 |
Why?
|
| Retinopathy of Prematurity | 1 | 2002 | 439 | 0.140 |
Why?
|
| Metabolic Diseases | 2 | 2015 | 683 | 0.140 |
Why?
|
| Receptors, Somatomedin | 10 | 1991 | 56 | 0.140 |
Why?
|
| Osteocalcin | 1 | 2017 | 274 | 0.140 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 564 | 0.140 |
Why?
|
| Serine | 4 | 2013 | 830 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 615 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2015 | 1961 | 0.140 |
Why?
|
| Diet | 2 | 2014 | 8075 | 0.140 |
Why?
|
| Finland | 1 | 2018 | 607 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 1998 | 436 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2047 | 0.130 |
Why?
|
| Risk Factors | 13 | 2024 | 74206 | 0.130 |
Why?
|
| Prostaglandins | 1 | 1997 | 398 | 0.130 |
Why?
|
| Cell Hypoxia | 4 | 2016 | 656 | 0.130 |
Why?
|
| Femoral Artery | 2 | 2019 | 826 | 0.130 |
Why?
|
| Heart | 3 | 2009 | 4404 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2005 | 4511 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 1995 | 1991 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2007 | 1741 | 0.130 |
Why?
|
| Weight Gain | 1 | 2006 | 2348 | 0.130 |
Why?
|
| Myocardial Ischemia | 2 | 2006 | 2113 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2013 | 790 | 0.130 |
Why?
|
| Flow Cytometry | 3 | 2016 | 5869 | 0.130 |
Why?
|
| Blotting, Northern | 9 | 2004 | 1545 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 638 | 0.130 |
Why?
|
| Angiography | 1 | 2021 | 1595 | 0.130 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 1995 | 19 | 0.130 |
Why?
|
| Base Sequence | 8 | 2012 | 12441 | 0.130 |
Why?
|
| Phosphoproteins | 5 | 2005 | 2448 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 7594 | 0.120 |
Why?
|
| Autopsy | 1 | 2019 | 1008 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 1814 | 0.120 |
Why?
|
| Cell Membrane | 8 | 2007 | 3688 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2021 | 2471 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2004 | 10766 | 0.120 |
Why?
|
| Reference Values | 4 | 2007 | 4920 | 0.120 |
Why?
|
| Phospholipases A | 1 | 1995 | 204 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1776 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 789 | 0.120 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 254 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2007 | 255 | 0.120 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 6 | 2002 | 664 | 0.120 |
Why?
|
| Proteomics | 2 | 2019 | 3849 | 0.120 |
Why?
|
| Triglycerides | 3 | 2018 | 2461 | 0.120 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 129 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1486 | 0.110 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 3429 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2000 | 1525 | 0.110 |
Why?
|
| Creatinine | 1 | 1999 | 1899 | 0.110 |
Why?
|
| Myocytes, Cardiac | 3 | 2009 | 1668 | 0.110 |
Why?
|
| Galactosemias | 1 | 1994 | 124 | 0.110 |
Why?
|
| Sodium-Glucose Transport Proteins | 1 | 2013 | 13 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2015 | 250 | 0.110 |
Why?
|
| Eye | 1 | 1997 | 712 | 0.110 |
Why?
|
| Salix | 1 | 2012 | 3 | 0.110 |
Why?
|
| Methylglucosides | 1 | 1993 | 35 | 0.110 |
Why?
|
| Disease Progression | 5 | 2021 | 13506 | 0.110 |
Why?
|
| Cytosol | 5 | 1995 | 888 | 0.110 |
Why?
|
| Hemodynamics | 7 | 2003 | 4159 | 0.110 |
Why?
|
| Health | 2 | 2015 | 398 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 4352 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 829 | 0.110 |
Why?
|
| Regeneration | 1 | 2022 | 1511 | 0.110 |
Why?
|
| Malondialdehyde | 1 | 2012 | 112 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 676 | 0.110 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1992 | 110 | 0.100 |
Why?
|
| Biological Transport | 6 | 2003 | 2091 | 0.100 |
Why?
|
| Type C Phospholipases | 2 | 2007 | 287 | 0.100 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 93 | 0.100 |
Why?
|
| Threonine | 1 | 2013 | 271 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 473 | 0.100 |
Why?
|
| Autoantibodies | 3 | 2019 | 2116 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2021 | 41487 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 477 | 0.100 |
Why?
|
| Venoms | 1 | 2012 | 94 | 0.100 |
Why?
|
| Albuminuria | 5 | 2005 | 657 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 205 | 0.100 |
Why?
|
| Arterioles | 1 | 1992 | 250 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 411 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 329 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2016 | 10445 | 0.100 |
Why?
|
| Gangliosides | 2 | 1992 | 132 | 0.100 |
Why?
|
| Phorbol Esters | 1 | 1991 | 108 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2018 | 1349 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 290 | 0.090 |
Why?
|
| Epithelium | 3 | 1994 | 1603 | 0.090 |
Why?
|
| Thymidine | 5 | 1993 | 299 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 4016 | 0.090 |
Why?
|
| Hexosephosphates | 1 | 1990 | 26 | 0.090 |
Why?
|
| Mannosephosphates | 1 | 1990 | 11 | 0.090 |
Why?
|
| Fructose | 1 | 2013 | 288 | 0.090 |
Why?
|
| Molecular Sequence Data | 9 | 1998 | 17635 | 0.090 |
Why?
|
| Numismatics | 1 | 2010 | 16 | 0.090 |
Why?
|
| Monocytes | 2 | 2017 | 2570 | 0.090 |
Why?
|
| Alveolar Bone Loss | 1 | 2014 | 390 | 0.090 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 2088 | 0.090 |
Why?
|
| DNA | 11 | 2002 | 7212 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3448 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2014 | 759 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2007 | 6075 | 0.090 |
Why?
|
| Blood Flow Velocity | 6 | 2003 | 1371 | 0.090 |
Why?
|
| Flavonoids | 2 | 2006 | 445 | 0.090 |
Why?
|
| Receptors, Angiotensin | 3 | 2001 | 141 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58976 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2012 | 372 | 0.090 |
Why?
|
| Blindness | 2 | 2013 | 584 | 0.090 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2013 | 357 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2010 | 3087 | 0.080 |
Why?
|
| Protein C | 1 | 2010 | 133 | 0.080 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2009 | 21 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2016 | 3615 | 0.080 |
Why?
|
| Reperfusion | 1 | 2010 | 271 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 237 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3778 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 498 | 0.080 |
Why?
|
| Peptides, Cyclic | 4 | 2000 | 392 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 4758 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 184 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2018 | 12953 | 0.080 |
Why?
|
| Binding, Competitive | 7 | 1993 | 1141 | 0.080 |
Why?
|
| Peptide Fragments | 5 | 2015 | 5112 | 0.080 |
Why?
|
| Cholesterol | 1 | 2018 | 2904 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2003 | 1084 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 629 | 0.080 |
Why?
|
| Amino Acid Sequence | 9 | 1995 | 13446 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2932 | 0.080 |
Why?
|
| Molecular Weight | 5 | 1993 | 2186 | 0.080 |
Why?
|
| Caspase 8 | 1 | 2008 | 190 | 0.080 |
Why?
|
| Renin-Angiotensin System | 1 | 2013 | 737 | 0.080 |
Why?
|
| Polysaccharide-Lyases | 1 | 2007 | 47 | 0.080 |
Why?
|
| Genes, Dominant | 2 | 2008 | 852 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 1989 | 321 | 0.070 |
Why?
|
| Tritium | 3 | 1994 | 708 | 0.070 |
Why?
|
| Rats, Inbred BN | 3 | 1996 | 231 | 0.070 |
Why?
|
| Troponin I | 2 | 2005 | 651 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 39 | 0.070 |
Why?
|
| Arginine | 1 | 2011 | 934 | 0.070 |
Why?
|
| Oxidants | 2 | 2004 | 169 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9606 | 0.070 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 61 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14605 | 0.070 |
Why?
|
| Endocytosis | 1 | 1991 | 957 | 0.070 |
Why?
|
| Immunologic Techniques | 2 | 2002 | 212 | 0.070 |
Why?
|
| Phenotype | 3 | 2011 | 16591 | 0.070 |
Why?
|
| Captopril | 1 | 2007 | 265 | 0.070 |
Why?
|
| Lysine | 1 | 2011 | 993 | 0.070 |
Why?
|
| Islets of Langerhans | 3 | 2007 | 1341 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 1999 | 3415 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 15842 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1533 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1006 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2012 | 988 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 5789 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 743 | 0.060 |
Why?
|
| Adult | 18 | 2021 | 221177 | 0.060 |
Why?
|
| Hexosamines | 1 | 2005 | 40 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2446 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 55 | 0.060 |
Why?
|
| Aorta, Abdominal | 3 | 1999 | 625 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.060 |
Why?
|
| Proteins | 1 | 2000 | 6032 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2006 | 395 | 0.060 |
Why?
|
| United States | 7 | 2021 | 72334 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1995 | 1058 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 1987 | 701 | 0.060 |
Why?
|
| RNA | 4 | 2007 | 2726 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2018 | 9318 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1997 | 435 | 0.060 |
Why?
|
| Arachidonic Acid | 2 | 1997 | 427 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 4061 | 0.060 |
Why?
|
| Trypsin | 3 | 1994 | 495 | 0.060 |
Why?
|
| Genotype | 3 | 2018 | 12990 | 0.060 |
Why?
|
| Public Health Practice | 1 | 2006 | 219 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2014 | 8631 | 0.060 |
Why?
|
| Adenosine | 3 | 1998 | 808 | 0.060 |
Why?
|
| Androstadienes | 1 | 2006 | 348 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2000 | 1791 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2018 | 3979 | 0.060 |
Why?
|
| Photoreceptor Cells | 1 | 2005 | 236 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 840 | 0.060 |
Why?
|
| Monensin | 3 | 1988 | 30 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2008 | 719 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2012 | 1456 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5247 | 0.050 |
Why?
|
| Leukostasis | 1 | 2003 | 23 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2003 | 56 | 0.050 |
Why?
|
| Liver | 3 | 2013 | 7529 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9326 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15732 | 0.050 |
Why?
|
| Plasma | 1 | 2006 | 586 | 0.050 |
Why?
|
| Logistic Models | 1 | 2018 | 13255 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20098 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2013 | 2690 | 0.050 |
Why?
|
| Thioredoxins | 1 | 2004 | 202 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2005 | 2872 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.050 |
Why?
|
| Muramidase | 1 | 2002 | 169 | 0.050 |
Why?
|
| Adolescent | 8 | 2019 | 88319 | 0.050 |
Why?
|
| Fibronectins | 2 | 1997 | 723 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 961 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2000 | 558 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 1516 | 0.050 |
Why?
|
| Vasa Nervorum | 1 | 2001 | 5 | 0.050 |
Why?
|
| Adiposity | 1 | 2011 | 1878 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 413 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 269 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 1188 | 0.050 |
Why?
|
| Endothelin-3 | 1 | 2000 | 9 | 0.050 |
Why?
|
| Body Weight | 2 | 2014 | 4618 | 0.050 |
Why?
|
| Pregnancy in Diabetics | 1 | 2002 | 197 | 0.050 |
Why?
|
| Dogs | 4 | 1997 | 3839 | 0.050 |
Why?
|
| Arteries | 1 | 1985 | 1123 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2002 | 294 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2000 | 343 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2002 | 496 | 0.040 |
Why?
|
| Genes, myc | 1 | 2001 | 390 | 0.040 |
Why?
|
| Thrombin | 1 | 2002 | 591 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2022 | 454 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 641 | 0.040 |
Why?
|
| Ischemia | 3 | 2010 | 1882 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2003 | 655 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 461 | 0.040 |
Why?
|
| Imidazoles | 2 | 2012 | 1180 | 0.040 |
Why?
|
| Lipoproteins | 2 | 2019 | 881 | 0.040 |
Why?
|
| Probucol | 1 | 1999 | 25 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39106 | 0.040 |
Why?
|
| von Willebrand Factor | 2 | 2000 | 673 | 0.040 |
Why?
|
| China | 1 | 2006 | 2369 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1999 | 317 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 154 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 176 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2002 | 545 | 0.040 |
Why?
|
| Receptors, Purinergic P1 | 2 | 1996 | 108 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 383 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3816 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2002 | 853 | 0.040 |
Why?
|
| Saralasin | 2 | 1996 | 34 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 1999 | 361 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2009 | 1515 | 0.040 |
Why?
|
| Phosphotyrosine | 2 | 1996 | 456 | 0.040 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 1998 | 39 | 0.040 |
Why?
|
| Receptor, trkA | 1 | 1999 | 159 | 0.040 |
Why?
|
| Administration, Oral | 2 | 1997 | 4021 | 0.040 |
Why?
|
| Glucose Intolerance | 2 | 2014 | 575 | 0.040 |
Why?
|
| Glycopeptides | 2 | 1996 | 220 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12690 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2003 | 1880 | 0.040 |
Why?
|
| Temperature | 4 | 1990 | 2226 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 321 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 1085 | 0.040 |
Why?
|
| Metalloendopeptidases | 2 | 1996 | 393 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 659 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 795 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2001 | 479 | 0.040 |
Why?
|
| U937 Cells | 1 | 2017 | 261 | 0.040 |
Why?
|
| DNA, Antisense | 1 | 1996 | 44 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2004 | 1206 | 0.040 |
Why?
|
| Brain | 4 | 2009 | 27112 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 586 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2003 | 1608 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2000 | 2078 | 0.030 |
Why?
|
| Chloroquine | 3 | 1986 | 274 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1996 | 176 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2004 | 1356 | 0.030 |
Why?
|
| Injections | 2 | 2000 | 830 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1996 | 131 | 0.030 |
Why?
|
| Renal Plasma Flow | 1 | 1996 | 27 | 0.030 |
Why?
|
| Renal Circulation | 1 | 1997 | 291 | 0.030 |
Why?
|
| Phosphopeptides | 2 | 1994 | 240 | 0.030 |
Why?
|
| Protease Inhibitors | 2 | 1996 | 754 | 0.030 |
Why?
|
| Retinal Diseases | 2 | 2000 | 705 | 0.030 |
Why?
|
| Quinazolinones | 1 | 1997 | 221 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2009 | 3879 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2006 | 8481 | 0.030 |
Why?
|
| Trisaccharides | 1 | 1995 | 50 | 0.030 |
Why?
|
| Rubidium | 1 | 1995 | 122 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2002 | 1569 | 0.030 |
Why?
|
| Blood | 1 | 1998 | 596 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1981 | 1071 | 0.030 |
Why?
|
| Palmitates | 1 | 1995 | 70 | 0.030 |
Why?
|
| Calcium | 2 | 1999 | 5722 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 197 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 2425 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1995 | 328 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9177 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 187 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 1995 | 294 | 0.030 |
Why?
|
| Plasminogen | 1 | 1995 | 144 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 1994 | 53 | 0.030 |
Why?
|
| Dietary Fats | 2 | 2014 | 1995 | 0.030 |
Why?
|
| CHO Cells | 2 | 1994 | 1387 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 951 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 1726 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 59243 | 0.030 |
Why?
|
| Cross-Linking Reagents | 2 | 1988 | 687 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 1023 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3096 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1997 | 597 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1996 | 258 | 0.030 |
Why?
|
| Child | 4 | 2019 | 80153 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 15936 | 0.030 |
Why?
|
| Rats, Inbred BB | 1 | 1993 | 29 | 0.030 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1993 | 41 | 0.030 |
Why?
|
| Pyridines | 2 | 2012 | 2875 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2026 | 0.030 |
Why?
|
| Iron-Sulfur Proteins | 1 | 1994 | 83 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 541 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1997 | 838 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6055 | 0.030 |
Why?
|
| Luciferases | 2 | 2008 | 714 | 0.030 |
Why?
|
| Quality of Life | 2 | 2017 | 13367 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 1994 | 149 | 0.030 |
Why?
|
| Cricetinae | 2 | 1994 | 2423 | 0.030 |
Why?
|
| Heart Failure | 3 | 2012 | 11669 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1987 | 2561 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 393 | 0.030 |
Why?
|
| Oxidation-Reduction | 3 | 2005 | 2231 | 0.030 |
Why?
|
| Galactose | 1 | 1994 | 297 | 0.030 |
Why?
|
| Plant Bark | 1 | 2012 | 9 | 0.030 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2012 | 23 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1995 | 556 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1984 | 2479 | 0.030 |
Why?
|
| Benzyl Alcohols | 1 | 2012 | 30 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1999 | 1096 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1994 | 233 | 0.030 |
Why?
|
| Polysaccharides | 1 | 1999 | 1014 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2005 | 1974 | 0.030 |
Why?
|
| Veins | 1 | 1997 | 768 | 0.030 |
Why?
|
| Piperidines | 2 | 2000 | 1656 | 0.030 |
Why?
|
| Monosaccharides | 1 | 1993 | 68 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1994 | 405 | 0.030 |
Why?
|
| Species Specificity | 2 | 2011 | 2414 | 0.030 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 99 | 0.030 |
Why?
|
| Alleles | 2 | 2018 | 6863 | 0.030 |
Why?
|
| Insulin Infusion Systems | 1 | 1994 | 217 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1996 | 1132 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 9420 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 2819 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2001 | 178 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 1996 | 1039 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 517 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1991 | 304 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 3 | 1982 | 445 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1995 | 983 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2008 | 1529 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 1995 | 1827 | 0.020 |
Why?
|
| Quinazolines | 1 | 1997 | 1371 | 0.020 |
Why?
|
| Laser Coagulation | 2 | 2004 | 330 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2006 | 3429 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Genes | 1 | 1995 | 1823 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 361 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1990 | 35 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4936 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3606 | 0.020 |
Why?
|
| DNA Replication | 3 | 1989 | 1418 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1474 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 452 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1999 | 6228 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2012 | 12128 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 730 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1995 | 941 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 371 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2014 | 935 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 185 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2002 | 3807 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 4174 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2748 | 0.020 |
Why?
|
| Random Allocation | 1 | 1994 | 2395 | 0.020 |
Why?
|
| Autoantigens | 1 | 1994 | 891 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1995 | 952 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1999 | 1310 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10209 | 0.020 |
Why?
|
| Executive Function | 1 | 2018 | 1389 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 214 | 0.020 |
Why?
|
| Culture | 1 | 2013 | 623 | 0.020 |
Why?
|
| Sorbitol | 1 | 1989 | 57 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2014 | 952 | 0.020 |
Why?
|
| Collagen | 1 | 1997 | 2638 | 0.020 |
Why?
|
| Solubility | 3 | 1999 | 1091 | 0.020 |
Why?
|
| Ouabain | 1 | 1989 | 247 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2000 | 12341 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1998 | 1978 | 0.020 |
Why?
|
| Reoviridae | 1 | 1989 | 162 | 0.020 |
Why?
|
| Neuraminidase | 1 | 1989 | 196 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 391 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 1995 | 9000 | 0.020 |
Why?
|
| Glycerol | 1 | 1989 | 274 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 513 | 0.020 |
Why?
|
| Metformin | 1 | 1996 | 906 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1989 | 561 | 0.020 |
Why?
|
| Glucosides | 1 | 2012 | 512 | 0.020 |
Why?
|
| Macromolecular Substances | 3 | 1993 | 1434 | 0.020 |
Why?
|
| Inositol | 1 | 1989 | 215 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2015 | 834 | 0.020 |
Why?
|
| Autoradiography | 2 | 1985 | 728 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1987 | 235 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12725 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 624 | 0.020 |
Why?
|
| Leupeptins | 1 | 1986 | 113 | 0.020 |
Why?
|
| Video Recording | 1 | 1992 | 966 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 1596 | 0.020 |
Why?
|
| Antigens | 1 | 1992 | 1443 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2134 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2005 | 64680 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 874 | 0.020 |
Why?
|
| Diffusion | 1 | 1987 | 814 | 0.020 |
Why?
|
| Succinimides | 1 | 1985 | 81 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2522 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 1989 | 640 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 943 | 0.020 |
Why?
|
| Retinal Artery | 1 | 1985 | 109 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1988 | 1031 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10194 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 1603 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2382 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2017 | 10090 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2013 | 2495 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 4227 | 0.010 |
Why?
|
| Amino Acids | 1 | 1990 | 1718 | 0.010 |
Why?
|
| Sulfonylurea Compounds | 1 | 1985 | 219 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1860 | 0.010 |
Why?
|
| Drug Stability | 1 | 1984 | 291 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1998 | 1463 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1984 | 426 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 506 | 0.010 |
Why?
|
| Thioctic Acid | 1 | 2003 | 28 | 0.010 |
Why?
|
| Cytochalasins | 1 | 1982 | 19 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 2 | 2004 | 2169 | 0.010 |
Why?
|
| Acetophenones | 1 | 2002 | 53 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1982 | 91 | 0.010 |
Why?
|
| Chromones | 1 | 2002 | 148 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1985 | 569 | 0.010 |
Why?
|
| Benzopyrans | 1 | 2002 | 63 | 0.010 |
Why?
|
| Glycogen | 1 | 1983 | 251 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2003 | 126 | 0.010 |
Why?
|
| GATA2 Transcription Factor | 1 | 2002 | 158 | 0.010 |
Why?
|
| Decidua | 1 | 2002 | 82 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2007 | 811 | 0.010 |
Why?
|
| Cell Separation | 1 | 1988 | 1720 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 621 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2003 | 383 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 277 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3792 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1982 | 117 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17904 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3188 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2002 | 364 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2713 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 728 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 26198 | 0.010 |
Why?
|
| Aspirin | 2 | 2004 | 3133 | 0.010 |
Why?
|
| Life Style | 1 | 2013 | 3917 | 0.010 |
Why?
|
| Insulin Antibodies | 1 | 1981 | 28 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 1310 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10552 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 891 | 0.010 |
Why?
|
| Protein Binding | 2 | 2004 | 9351 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2001 | 153 | 0.010 |
Why?
|
| Colchicine | 1 | 1982 | 259 | 0.010 |
Why?
|
| Vinblastine | 1 | 1982 | 488 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 2000 | 108 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1787 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 587 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 1141 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 2002 | 332 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 931 | 0.010 |
Why?
|
| Microspheres | 1 | 2003 | 784 | 0.010 |
Why?
|
| Iontophoresis | 1 | 1999 | 74 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2919 | 0.010 |
Why?
|
| Morpholines | 1 | 2002 | 581 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 329 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1999 | 272 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1982 | 296 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2678 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7827 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2008 | 1298 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 545 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2006 | 1186 | 0.010 |
Why?
|
| Bucladesine | 1 | 1998 | 118 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 811 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 926 | 0.010 |
Why?
|
| Genes, jun | 1 | 1998 | 69 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1982 | 803 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2005 | 1985 | 0.010 |
Why?
|
| Genes, fos | 1 | 1998 | 176 | 0.010 |
Why?
|
| Mitogens | 1 | 1998 | 230 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1998 | 186 | 0.010 |
Why?
|
| Insulinoma | 1 | 1998 | 121 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 1509 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 3358 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1982 | 983 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 629 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1984 | 1440 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 2665 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2000 | 888 | 0.010 |
Why?
|
| Zinc | 1 | 1981 | 690 | 0.010 |
Why?
|
| Retroelements | 1 | 1998 | 163 | 0.010 |
Why?
|
| Heart Rate | 1 | 2009 | 4195 | 0.010 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1996 | 45 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1998 | 352 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1749 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1986 | 2413 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1756 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2013 | 4686 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1675 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2001 | 1674 | 0.010 |
Why?
|
| ras Proteins | 1 | 2001 | 1054 | 0.010 |
Why?
|
| Swine | 2 | 1983 | 5915 | 0.010 |
Why?
|
| Acarbose | 1 | 1995 | 10 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9463 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1981 | 3076 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1705 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 542 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 2416 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 2856 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1187 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1863 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 1900 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5791 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1996 | 311 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 3395 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 484 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 167 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 21353 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1995 | 246 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2909 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1996 | 592 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1994 | 158 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1600 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 685 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1995 | 647 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1999 | 829 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1992 | 138 | 0.010 |
Why?
|
| Indicators and Reagents | 2 | 1983 | 462 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80636 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1995 | 317 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 317 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8708 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 3323 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 2751 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6343 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6132 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1998 | 1088 | 0.010 |
Why?
|
| Biological Assay | 2 | 1983 | 626 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1993 | 1693 | 0.010 |
Why?
|
| Respiration | 1 | 1996 | 1657 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 2 | 1982 | 510 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 2244 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1541 | 0.010 |
Why?
|
| Mammalian orthoreovirus 3 | 1 | 1989 | 45 | 0.010 |
Why?
|
| Hemagglutinins, Viral | 1 | 1989 | 66 | 0.010 |
Why?
|
| Thrombosis | 1 | 2002 | 2942 | 0.000 |
Why?
|
| Age Factors | 1 | 2005 | 18395 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3734 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1995 | 3162 | 0.000 |
Why?
|
| Skin | 1 | 1999 | 4484 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7390 | 0.000 |
Why?
|
| Affinity Labels | 1 | 1984 | 107 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 30052 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 645 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1995 | 4544 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11076 | 0.000 |
Why?
|
| Chymotrypsin | 1 | 1982 | 138 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11528 | 0.000 |
Why?
|
| Models, Structural | 1 | 1981 | 340 | 0.000 |
Why?
|
| Pregnancy | 1 | 2002 | 29874 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1998 | 5368 | 0.000 |
Why?
|
| Insulin Antagonists | 1 | 1980 | 17 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1982 | 1060 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1980 | 862 | 0.000 |
Why?
|
| Epitopes | 1 | 1982 | 2503 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1981 | 3968 | 0.000 |
Why?
|